A review of pharmacotherapeutics for prosthetic dentistry: Part I.
BACKGROUND
Success or failure of a clinical procedure often hinges on the proper application of pharmacologic principles of locally acting drugs. The competent and successful practitioner must therefore have a good background in basic pharmacology, be knowledgeable of pharmacotherapeutics, and keep abreast of the latest advances in medicinal agents.


OBJECTIVE
The purpose of this article is to review pharmacologic properties of prototype and new drugs that are particularly useful for operative procedures and treatment of the oral cavity. The information presented should enable clinicians to improve clinical outcomes and make a more knowledgeable assessment and comparison of standard drugs with recently released drugs.
Felpel
L P
LP
University of Texas Health Science Center at San Antonio, USA.
D000287:Administration, Topical; D000779:Anesthetics, Local; D001252:Astringents; D018679:Cholinergic Agonists / Q000494:pharmacology; D018680:Cholinergic Antagonists / Q000494:pharmacology; D004358:Drug Therapy; D004363:Drug Utilization; D015507:Drugs, Investigational; D006490:Hemostatics; D006801:Humans; D009067:Mouthwashes; D004366:Nonprescription Drugs; D010277:Parasympathomimetics; D011476:Prosthodontics; D012472:Salivation / Q000187:drug effects; D014662:Vasoconstrictor Agents
D000779:Anesthetics, Local; D001252:Astringents; D018679:Cholinergic Agonists; D018680:Cholinergic Antagonists; D015507:Drugs, Investigational; D006490:Hemostatics; D009067:Mouthwashes; D004366:Nonprescription Drugs; D010277:Parasympathomimetics; D014662:Vasoconstrictor Agents